Autocrine transforming growth factor‐β1 activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts

Diana V. Messadi, Steve Berg, Kyoo Sung‐Cho, Malcolm Lesavoy, Charles Bertolami

Research output: Contribution to journalArticle

Abstract

Transforming growth factor‐β1 is a well‐known and potent biological response modifier that plays an important role in tissue repair and fibrosis. Among the extracellular constituents known to accumulate in fibrotic tissues, glycosaminoglycans are prominent. In this study we examined transforming growth factor‐β1 synthesis by human dermal fibroblasts derived from both normal and fibrotic cutaneous tissues. We studied the influence of transforming growth factor‐β1 on glycosaminoglycan synthesis and explored the role of transforming growth factor‐β1 as an autocrine mediator of its own expression. These investigations are directed at understanding the persistence of the fibrotic phenotype in scarred skin. Transforming growth factor‐β1 activity was measured by means of a mink lung epithelium growth inhibitory assay. Replicate explants (n = 3) of fibroblasts each derived from normal skin, normal scar, or hypertrophic scar were studied by adding exogenous transforming growth factor‐β1 at a concentration range of 0 to 10 ng/ml. The resulting conditioned media were removed and assayed for transforming growth factor‐β1 activity, then the cells were pulsed for an additional 24 hours with radiolabeled glycosaminoglycan precursor, [3H]‐glucosamine, to evaluate glycosaminoglycan production. Cell‐free glycosaminoglycan synthetic profiles were also developed. Transforming growth factor‐β1 was found to cause a dose‐dependent increase in glycosaminoglycan synthesis in hypertrophic scar and normal skin but not in normal scar fibroblasts in cell‐mediated glycosaminoglycan synthesis; the reverse was observed in cell‐free glycosaminoglycan synthesis, where transforming growth factor‐β1 increased glycosaminoglycan synthesis in normal scar but not in normal skin or hypertrophic scar. Most endogenous transforming growth factor‐β1 existed in latent form for normal skin cells but in active form for normal scar and hypertrophic scar fibroblasts.

Original languageEnglish (US)
Pages (from-to)284-291
Number of pages8
JournalWound Repair and Regeneration
Volume2
Issue number4
DOIs
StatePublished - 1994

Fingerprint

Glycosaminoglycans
Cicatrix
Fibroblasts
Skin
Growth
Hypertrophic Cicatrix
Mink
Glucosamine
Immunologic Factors
Conditioned Culture Medium
Fibrosis
Epithelium
Phenotype
Lung

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Autocrine transforming growth factor‐β1 activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts. / Messadi, Diana V.; Berg, Steve; Sung‐Cho, Kyoo; Lesavoy, Malcolm; Bertolami, Charles.

In: Wound Repair and Regeneration, Vol. 2, No. 4, 1994, p. 284-291.

Research output: Contribution to journalArticle

Messadi, Diana V. ; Berg, Steve ; Sung‐Cho, Kyoo ; Lesavoy, Malcolm ; Bertolami, Charles. / Autocrine transforming growth factor‐β1 activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts. In: Wound Repair and Regeneration. 1994 ; Vol. 2, No. 4. pp. 284-291.
@article{d48e9004877f4791992c8df0620f7949,
title = "Autocrine transforming growth factor‐β1 activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts",
abstract = "Transforming growth factor‐β1 is a well‐known and potent biological response modifier that plays an important role in tissue repair and fibrosis. Among the extracellular constituents known to accumulate in fibrotic tissues, glycosaminoglycans are prominent. In this study we examined transforming growth factor‐β1 synthesis by human dermal fibroblasts derived from both normal and fibrotic cutaneous tissues. We studied the influence of transforming growth factor‐β1 on glycosaminoglycan synthesis and explored the role of transforming growth factor‐β1 as an autocrine mediator of its own expression. These investigations are directed at understanding the persistence of the fibrotic phenotype in scarred skin. Transforming growth factor‐β1 activity was measured by means of a mink lung epithelium growth inhibitory assay. Replicate explants (n = 3) of fibroblasts each derived from normal skin, normal scar, or hypertrophic scar were studied by adding exogenous transforming growth factor‐β1 at a concentration range of 0 to 10 ng/ml. The resulting conditioned media were removed and assayed for transforming growth factor‐β1 activity, then the cells were pulsed for an additional 24 hours with radiolabeled glycosaminoglycan precursor, [3H]‐glucosamine, to evaluate glycosaminoglycan production. Cell‐free glycosaminoglycan synthetic profiles were also developed. Transforming growth factor‐β1 was found to cause a dose‐dependent increase in glycosaminoglycan synthesis in hypertrophic scar and normal skin but not in normal scar fibroblasts in cell‐mediated glycosaminoglycan synthesis; the reverse was observed in cell‐free glycosaminoglycan synthesis, where transforming growth factor‐β1 increased glycosaminoglycan synthesis in normal scar but not in normal skin or hypertrophic scar. Most endogenous transforming growth factor‐β1 existed in latent form for normal skin cells but in active form for normal scar and hypertrophic scar fibroblasts.",
author = "Messadi, {Diana V.} and Steve Berg and Kyoo Sung‐Cho and Malcolm Lesavoy and Charles Bertolami",
year = "1994",
doi = "10.1046/j.1524-475X.1994.20409.x",
language = "English (US)",
volume = "2",
pages = "284--291",
journal = "Wound Repair and Regeneration",
issn = "1067-1927",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Autocrine transforming growth factor‐β1 activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts

AU - Messadi, Diana V.

AU - Berg, Steve

AU - Sung‐Cho, Kyoo

AU - Lesavoy, Malcolm

AU - Bertolami, Charles

PY - 1994

Y1 - 1994

N2 - Transforming growth factor‐β1 is a well‐known and potent biological response modifier that plays an important role in tissue repair and fibrosis. Among the extracellular constituents known to accumulate in fibrotic tissues, glycosaminoglycans are prominent. In this study we examined transforming growth factor‐β1 synthesis by human dermal fibroblasts derived from both normal and fibrotic cutaneous tissues. We studied the influence of transforming growth factor‐β1 on glycosaminoglycan synthesis and explored the role of transforming growth factor‐β1 as an autocrine mediator of its own expression. These investigations are directed at understanding the persistence of the fibrotic phenotype in scarred skin. Transforming growth factor‐β1 activity was measured by means of a mink lung epithelium growth inhibitory assay. Replicate explants (n = 3) of fibroblasts each derived from normal skin, normal scar, or hypertrophic scar were studied by adding exogenous transforming growth factor‐β1 at a concentration range of 0 to 10 ng/ml. The resulting conditioned media were removed and assayed for transforming growth factor‐β1 activity, then the cells were pulsed for an additional 24 hours with radiolabeled glycosaminoglycan precursor, [3H]‐glucosamine, to evaluate glycosaminoglycan production. Cell‐free glycosaminoglycan synthetic profiles were also developed. Transforming growth factor‐β1 was found to cause a dose‐dependent increase in glycosaminoglycan synthesis in hypertrophic scar and normal skin but not in normal scar fibroblasts in cell‐mediated glycosaminoglycan synthesis; the reverse was observed in cell‐free glycosaminoglycan synthesis, where transforming growth factor‐β1 increased glycosaminoglycan synthesis in normal scar but not in normal skin or hypertrophic scar. Most endogenous transforming growth factor‐β1 existed in latent form for normal skin cells but in active form for normal scar and hypertrophic scar fibroblasts.

AB - Transforming growth factor‐β1 is a well‐known and potent biological response modifier that plays an important role in tissue repair and fibrosis. Among the extracellular constituents known to accumulate in fibrotic tissues, glycosaminoglycans are prominent. In this study we examined transforming growth factor‐β1 synthesis by human dermal fibroblasts derived from both normal and fibrotic cutaneous tissues. We studied the influence of transforming growth factor‐β1 on glycosaminoglycan synthesis and explored the role of transforming growth factor‐β1 as an autocrine mediator of its own expression. These investigations are directed at understanding the persistence of the fibrotic phenotype in scarred skin. Transforming growth factor‐β1 activity was measured by means of a mink lung epithelium growth inhibitory assay. Replicate explants (n = 3) of fibroblasts each derived from normal skin, normal scar, or hypertrophic scar were studied by adding exogenous transforming growth factor‐β1 at a concentration range of 0 to 10 ng/ml. The resulting conditioned media were removed and assayed for transforming growth factor‐β1 activity, then the cells were pulsed for an additional 24 hours with radiolabeled glycosaminoglycan precursor, [3H]‐glucosamine, to evaluate glycosaminoglycan production. Cell‐free glycosaminoglycan synthetic profiles were also developed. Transforming growth factor‐β1 was found to cause a dose‐dependent increase in glycosaminoglycan synthesis in hypertrophic scar and normal skin but not in normal scar fibroblasts in cell‐mediated glycosaminoglycan synthesis; the reverse was observed in cell‐free glycosaminoglycan synthesis, where transforming growth factor‐β1 increased glycosaminoglycan synthesis in normal scar but not in normal skin or hypertrophic scar. Most endogenous transforming growth factor‐β1 existed in latent form for normal skin cells but in active form for normal scar and hypertrophic scar fibroblasts.

UR - http://www.scopus.com/inward/record.url?scp=84989152386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989152386&partnerID=8YFLogxK

U2 - 10.1046/j.1524-475X.1994.20409.x

DO - 10.1046/j.1524-475X.1994.20409.x

M3 - Article

VL - 2

SP - 284

EP - 291

JO - Wound Repair and Regeneration

JF - Wound Repair and Regeneration

SN - 1067-1927

IS - 4

ER -